Semaglutide (Wegovy) for secondary cardiovascular prevention in adults with an elevated BMI
Drug and therapeutics bulletin · 2026 Nov
MH
By Maren Holt · Senior Reporter, GLP-1
Nov 5 19:00 ETSource: Drug and therapeutics bulletin
From the source
Read at pubmed.ncbi.nlm.nih.govSemaglutide (Wegovy) for secondary cardiovascular prevention in adults with an elevated BMI
Drug and therapeutics bulletin · 2026 Nov 6
Source URL https://pubmed.ncbi.nlm.nih.gov/42994978/
